Matches in Wikidata for { <http://www.wikidata.org/entity/Q37202390> ?p ?o ?g. }
- Q37202390 description "article científic" @default.
- Q37202390 description "article scientifique" @default.
- Q37202390 description "articolo scientifico" @default.
- Q37202390 description "artigo científico" @default.
- Q37202390 description "artículu científicu espublizáu en 2016" @default.
- Q37202390 description "bilimsel makale" @default.
- Q37202390 description "scientific article published on 25 August 2016" @default.
- Q37202390 description "vedecký článok" @default.
- Q37202390 description "vetenskaplig artikel" @default.
- Q37202390 description "videnskabelig artikel" @default.
- Q37202390 description "vědecký článek" @default.
- Q37202390 description "wetenschappelijk artikel" @default.
- Q37202390 description "wissenschaftlicher Artikel" @default.
- Q37202390 description "наукова стаття, опублікована в серпні 2016" @default.
- Q37202390 description "научни чланак" @default.
- Q37202390 description "مقالة علمية نشرت في 25 أغسطس 2016" @default.
- Q37202390 name "Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling." @default.
- Q37202390 name "Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling." @default.
- Q37202390 name "Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling." @default.
- Q37202390 type Item @default.
- Q37202390 label "Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling." @default.
- Q37202390 label "Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling." @default.
- Q37202390 label "Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling." @default.
- Q37202390 prefLabel "Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling." @default.
- Q37202390 prefLabel "Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling." @default.
- Q37202390 prefLabel "Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling." @default.
- Q37202390 P1433 Q37202390-7F69E4E5-9C92-4A76-8DF3-F3922896984D @default.
- Q37202390 P1476 Q37202390-BC588AA3-B82C-4AF3-9973-8F8D319656C0 @default.
- Q37202390 P2093 Q37202390-038E72E1-8182-4E53-B3DA-E6132B659B18 @default.
- Q37202390 P2093 Q37202390-065F27B8-41AD-4FF9-A085-D21094C2EE1E @default.
- Q37202390 P2093 Q37202390-11E55224-8945-45EF-98BD-17F5DE069EF6 @default.
- Q37202390 P2093 Q37202390-49197195-AFD4-4DBE-91BA-10760BDBC709 @default.
- Q37202390 P2093 Q37202390-634CE49B-B50A-4861-B117-5E1E95DBDA2B @default.
- Q37202390 P2093 Q37202390-787DC9C1-B90B-48AF-ACFE-18EF682AA848 @default.
- Q37202390 P2093 Q37202390-93B91E7B-371D-494D-B858-7D2BDCF8CC2A @default.
- Q37202390 P2093 Q37202390-D8437EEF-F8A1-4D80-B8A0-A07E594AFFDE @default.
- Q37202390 P275 Q37202390-c0eca508-7d5b-459c-93a1-796d12045e92 @default.
- Q37202390 P2860 Q37202390-05F8FEC0-B68B-48D4-B6AA-E2C72C206693 @default.
- Q37202390 P2860 Q37202390-0ADD118F-DB99-4685-A317-5F7936284BB2 @default.
- Q37202390 P2860 Q37202390-0EB7975B-723C-437B-AACE-4FC62EFE50C7 @default.
- Q37202390 P2860 Q37202390-133BED00-0C63-4CCC-A3C9-126777FBB7E6 @default.
- Q37202390 P2860 Q37202390-18B1894F-286E-4A89-BAB4-7E4840DF21DB @default.
- Q37202390 P2860 Q37202390-18C54DDC-347B-4FE8-889C-4113B36DFA4F @default.
- Q37202390 P2860 Q37202390-1AE9DD2D-4EAA-413F-BA31-109D7E28457F @default.
- Q37202390 P2860 Q37202390-214C3FF4-6CDE-4699-B8F0-2CDC37E53BC8 @default.
- Q37202390 P2860 Q37202390-226C8A4D-5F28-42F2-B4A5-9FC772DFA289 @default.
- Q37202390 P2860 Q37202390-2D3FA824-2C63-45AE-BEFD-BBC1F9032241 @default.
- Q37202390 P2860 Q37202390-2D7861D1-C8BA-4346-B074-EE247618188C @default.
- Q37202390 P2860 Q37202390-34F1699A-CC9B-43AF-8D0E-E0A2258C079B @default.
- Q37202390 P2860 Q37202390-3846D279-EAC4-480E-A7CC-21B63EEC0A64 @default.
- Q37202390 P2860 Q37202390-38C91A73-CDFE-4E7C-AA75-06D61528F2CD @default.
- Q37202390 P2860 Q37202390-4695BDF1-03C5-430C-B082-3868AEADFF0F @default.
- Q37202390 P2860 Q37202390-519C1413-272B-48A1-BF73-3D5F3198F9D2 @default.
- Q37202390 P2860 Q37202390-590F569C-39FB-4147-B1D6-08DA782EFEA9 @default.
- Q37202390 P2860 Q37202390-5CA6D54A-79E1-4659-BC65-EAFF51E4F386 @default.
- Q37202390 P2860 Q37202390-5FB38C19-A3E6-4B82-8E15-A87AF9E9A23C @default.
- Q37202390 P2860 Q37202390-7362A254-12CF-479B-9B5D-70E0687F8020 @default.
- Q37202390 P2860 Q37202390-73CA49ED-865D-46A3-8194-E7B70C80AAD9 @default.
- Q37202390 P2860 Q37202390-75DD5507-281B-432E-86F5-FC0FA9A7CC79 @default.
- Q37202390 P2860 Q37202390-79155054-D19E-493E-B585-AD2FC0DB2519 @default.
- Q37202390 P2860 Q37202390-7FE6B955-CAB5-4AAD-BB4C-5A8CF9BDBBD1 @default.
- Q37202390 P2860 Q37202390-81B67D88-85CE-4D6F-8065-4223112D72E7 @default.
- Q37202390 P2860 Q37202390-825CAAC2-CA11-4C46-8645-AA8DB7CF2E6B @default.
- Q37202390 P2860 Q37202390-8481330F-7C23-406C-921E-925193D73B4F @default.
- Q37202390 P2860 Q37202390-877AC95D-7052-4190-9F72-73ACE295576A @default.
- Q37202390 P2860 Q37202390-95CAC7DE-C5F2-43EF-8D40-CC663D709F5A @default.
- Q37202390 P2860 Q37202390-9A27449A-44C9-4185-975C-E895805886FF @default.
- Q37202390 P2860 Q37202390-9C3D8428-E133-4658-948C-1C1D19A36312 @default.
- Q37202390 P2860 Q37202390-B408A9D8-1D25-4FDC-9947-546FB13D1358 @default.
- Q37202390 P2860 Q37202390-B96F53EE-60AD-46E8-B4AB-4387A003728A @default.
- Q37202390 P2860 Q37202390-C8E66B11-17BA-495C-95A3-AC400F1C105F @default.
- Q37202390 P2860 Q37202390-CA98B9BE-F3C6-4E3C-87C6-9754118BFABA @default.
- Q37202390 P2860 Q37202390-D1337D15-3CFF-4A7C-9A24-3A62BC9E0F92 @default.
- Q37202390 P2860 Q37202390-D8BF8EC3-B9AD-4E2E-A0DD-5490AAAF95E2 @default.
- Q37202390 P2860 Q37202390-DBEB8ADB-52BB-4DA9-8433-1951A84C76AF @default.
- Q37202390 P2860 Q37202390-DF27D0A8-6263-420C-B67B-75A5DF0D8EF9 @default.
- Q37202390 P2860 Q37202390-EF9A229B-63E5-41F2-AC03-85FAF55FEC96 @default.
- Q37202390 P2860 Q37202390-F612F21D-65A5-495A-9745-A5F02AB11BC4 @default.
- Q37202390 P2860 Q37202390-F83D490C-A4D0-4119-A954-57AEDE4E4163 @default.
- Q37202390 P2888 Q37202390-9F474775-7241-4D1D-B899-52A9B913C9C2 @default.
- Q37202390 P304 Q37202390-E85708BE-D703-4A1A-BBA3-CC6624C762AB @default.
- Q37202390 P31 Q37202390-ED219728-B058-41A9-AD9A-ED58FE64CDDA @default.
- Q37202390 P356 Q37202390-2263DF3A-3235-44E2-89D2-97A17DE9A000 @default.
- Q37202390 P407 Q37202390-4A6F1BF0-525E-445B-921B-CA269ABADD71 @default.
- Q37202390 P478 Q37202390-1AE85927-757A-4C2D-9315-6A06EAA0A095 @default.
- Q37202390 P50 Q37202390-043C1B73-915F-4914-A210-B49EA87CC963 @default.
- Q37202390 P50 Q37202390-8EBE55A2-9EE9-4327-9AE8-7F65AE060ED8 @default.
- Q37202390 P50 Q37202390-A64DBA27-FCB3-4358-A764-77D2A23DECDE @default.
- Q37202390 P577 Q37202390-79FEC643-53D3-4530-90F7-17CB8FA57F74 @default.
- Q37202390 P6216 Q37202390-8d1cbd1c-31b8-4b90-8735-6d10ab0ac91f @default.
- Q37202390 P698 Q37202390-4FB4BA39-2DDF-4719-B2CF-9AC7B7F9DD34 @default.
- Q37202390 P921 Q37202390-9E6911B4-95F4-49A2-BF82-630596E9AA3B @default.
- Q37202390 P921 Q37202390-DDF02D37-2E3A-4D03-91D8-E15780DE7A30 @default.
- Q37202390 P932 Q37202390-9E35A772-9819-4754-A6FB-97C26B03D7E9 @default.
- Q37202390 P356 SREP31926 @default.
- Q37202390 P698 27558312 @default.
- Q37202390 P1433 Q2261792 @default.
- Q37202390 P1476 "Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling" @default.
- Q37202390 P2093 "Cathy W C Bi" @default.
- Q37202390 P2093 "Crystal Y Q Du" @default.